Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Xencor Inc has a consensus price target of $36.47 based on the ratings of 17 analysts. The high is $58 issued by Raymond James on October 13, 2022. The low is $6 issued by Barclays on May 8, 2025. The 3 most-recent analyst ratings were released by Barclays, Wells Fargo, and Wells Fargo on May 8, 2025, February 28, 2025, and December 12, 2024, respectively. With an average price target of $25.33 between Barclays, Wells Fargo, and Wells Fargo, there's an implied 214.31% upside for Xencor Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/08/2025 | Buy Now | -25.56% | Barclays | Peter Lawson42% | $22 → $6 | Maintains | Underweight | Get Alert |
04/21/2025 | Buy Now | — | William Blair | Matt Phipps22% | — | Initiates | → Outperform | Get Alert |
02/28/2025 | Buy Now | 309.43% | Wells Fargo | Eva Fortea Verdejo39% | $37 → $33 | Maintains | Overweight | Get Alert |
12/12/2024 | Buy Now | 359.06% | Wells Fargo | Eva Fortea Verdejo39% | → $37 | Initiates | → Overweight | Get Alert |
12/02/2024 | Buy Now | 272.21% | Piper Sandler | Edward Tenthoff50% | $20 → $30 | Upgrade | Neutral → Overweight | Get Alert |
11/08/2024 | Buy Now | 321.84% | BMO Capital | Etzer Darout44% | $32 → $34 | Reiterates | Outperform → Outperform | Get Alert |
11/07/2024 | Buy Now | 247.39% | JP Morgan | Brian Cheng39% | $27 → $28 | Maintains | Overweight | Get Alert |
09/26/2024 | Buy Now | 321.84% | RBC Capital | Gregory Renza47% | $31 → $34 | Maintains | Outperform | Get Alert |
08/06/2024 | Buy Now | 297.02% | BMO Capital | Etzer Darout44% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
08/06/2024 | Buy Now | 284.62% | RBC Capital | Gregory Renza47% | $31 → $31 | Reiterates | Outperform → Outperform | Get Alert |
07/31/2024 | Buy Now | 234.99% | JP Morgan | Brian Cheng39% | $30 → $27 | Maintains | Overweight | Get Alert |
06/14/2024 | Buy Now | 396.28% | Raymond James | Sean McCutcheon11% | $58 → $40 | Maintains | Strong Buy | Get Alert |
06/14/2024 | Buy Now | 297.02% | BMO Capital | Etzer Darout44% | $34 → $32 | Maintains | Outperform | Get Alert |
06/14/2024 | Buy Now | 284.62% | RBC Capital | Gregory Renza47% | $32 → $31 | Maintains | Outperform | Get Alert |
05/10/2024 | Buy Now | 346.65% | Wedbush | David Nierengarten57% | $34 → $36 | Maintains | Outperform | Get Alert |
04/16/2024 | Buy Now | 371.46% | BTIG | Kaveri Pohlman26% | $56 → $38 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | 297.02% | RBC Capital | Gregory Renza47% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
02/28/2024 | Buy Now | 197.77% | Piper Sandler | Edward Tenthoff50% | $37 → $24 | Downgrade | Overweight → Neutral | Get Alert |
02/28/2024 | Buy Now | 321.84% | BMO Capital | Etzer Darout44% | $38 → $34 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | 321.84% | Wedbush | David Nierengarten57% | $36 → $34 | Maintains | Outperform | Get Alert |
01/22/2024 | Buy Now | 520.35% | Mizuho | Mara Goldstein56% | $59 → $50 | Maintains | Buy | Get Alert |
11/08/2023 | Buy Now | 321.84% | Guggenheim | Michael Schmidt54% | $40 → $34 | Maintains | Buy | Get Alert |
11/08/2023 | Buy Now | 297.02% | RBC Capital | Gregory Renza47% | $36 → $32 | Maintains | Outperform | Get Alert |
11/08/2023 | Buy Now | 346.65% | Wedbush | David Nierengarten57% | $37 → $36 | Maintains | Outperform | Get Alert |
05/19/2023 | Buy Now | 421.09% | B of A Securities | Alec Stranahan33% | → $42 | Initiates | → Buy | Get Alert |
05/09/2023 | Buy Now | 346.65% | RBC Capital | Gregory Renza47% | → $36 | Reiterates | → Outperform | Get Alert |
05/09/2023 | Buy Now | 359.06% | Wedbush | David Nierengarten57% | $39 → $37 | Maintains | Outperform | Get Alert |
02/24/2023 | Buy Now | 421.09% | Canaccord Genuity | William Maughan71% | $48 → $42 | Maintains | Buy | Get Alert |
02/24/2023 | Buy Now | 421.09% | EF Hutton | Michael King43% | → $42 | Reiterates | → Buy | Get Alert |
02/13/2023 | Buy Now | 421.09% | JP Morgan | Brian Cheng39% | $37 → $42 | Maintains | Overweight | Get Alert |
02/10/2023 | Buy Now | 632.01% | Mizuho | Mara Goldstein56% | → $59 | Reiterates | → Buy | Get Alert |
01/31/2023 | Buy Now | 421.09% | EF Hutton | Michael King43% | → $42 | Initiates | → Buy | Get Alert |
01/30/2023 | Buy Now | 421.09% | EF Hutton | Michael King43% | → $42 | Initiates | → Buy | Get Alert |
12/06/2022 | Buy Now | — | Cowen & Co. | Boris Peaker49% | — | Initiates | → Outperform | Get Alert |
11/08/2022 | Buy Now | 346.65% | RBC Capital | Gregory Renza47% | $40 → $36 | Maintains | Outperform | Get Alert |
10/13/2022 | Buy Now | 619.6% | Raymond James | Dane Leone45% | → $58 | Upgrade | Outperform → Strong Buy | Get Alert |
09/21/2022 | Buy Now | 359.06% | JP Morgan | Brian Cheng39% | → $37 | Initiates | → Overweight | Get Alert |
07/06/2022 | Buy Now | 520.35% | Canaccord Genuity | William Maughan71% | → $50 | Assumes | → Buy | Get Alert |
05/23/2022 | Buy Now | 421.09% | Piper Sandler | Edward Tenthoff50% | $66 → $42 | Maintains | Overweight | Get Alert |
The latest price target for Xencor (NASDAQ:XNCR) was reported by Barclays on May 8, 2025. The analyst firm set a price target for $6.00 expecting XNCR to fall to within 12 months (a possible -25.56% downside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Xencor (NASDAQ:XNCR) was provided by Barclays, and Xencor maintained their underweight rating.
The last upgrade for Xencor Inc happened on December 2, 2024 when Piper Sandler raised their price target to $30. Piper Sandler previously had a neutral for Xencor Inc.
The last downgrade for Xencor Inc happened on February 28, 2024 when Piper Sandler changed their price target from $37 to $24 for Xencor Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xencor, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xencor was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
While ratings are subjective and will change, the latest Xencor (XNCR) rating was a maintained with a price target of $22.00 to $6.00. The current price Xencor (XNCR) is trading at is $8.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.